Bolt Biotherapeutics Inc (BOLT)

Bolt Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Bolt’s proprietary Boltbody™ Immune-stimulating Antibody Conjugate (ISAC) approach combines an antibody that targets a tumor antigen with an immune stimulant that triggers an innate and adaptive immune response in the tumor microenvironment. These systemically-delivered Boltbody ISACs are designed to target tumor cells for elimination by myeloid cells, which are then activated and recruit the adaptive immune system in the anti-tumor response. This leads to the conversion of immunologically “cold” tumors to “hot” tumors. Bolt’s lead candidate, BDC-1001, is a Boltbody ISAC comprised of a HER2-targeting biosimilar of trastuzumab conjugated with a non-cleavable linker to one of Bolt’s proprietary TLR7/8 agonists for the treatment of patients with HER2-expressing solid tumors. Bolt is also advancing BDC-2034, a Boltbody ISAC targeting CEA, and a pipeline of other immuno-oncology products.

Data as of 2021-08-02 09:23:58 -0400
Market Cap405.17 Million Shares Outstanding36.338 Million Avg 30-day Volume99.215 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low43.07 / 10.75 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 0 3 (0.18%) No data
Funds Holding: 71 0 32 (1.88%) No data
13F shares: 31.49 Million 0 18.226 Million No data
% Ownership 98.8806 57.2305 No data
New Positions: 70 32 No data
Increased Positions No data
Closed Positions No data
Reduced Positions No data
Total Calls No data
Total Puts No data
PUT/CALL Ratio No data No data
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding BOLT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BOLT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 22:15:03 UTC -1.0841 1.1441 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 21:45:03 UTC -1.0841 1.1441 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 21:15:03 UTC -1.0841 1.1441 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 20:45:03 UTC -1.0841 1.1441 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 20:15:03 UTC -1.0841 1.1441 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 19:45:03 UTC -1.0841 1.1441 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 19:15:03 UTC -1.0841 1.1441 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 18:45:03 UTC -1.0841 1.1441 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 18:15:03 UTC -1.0841 1.1441 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 17:45:03 UTC -1.0841 1.1441 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 17:15:03 UTC -1.0841 1.1441 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 16:45:03 UTC -1.0858 1.1658 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 16:15:03 UTC -1.0858 1.1658 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 15:45:03 UTC -1.0858 1.1658 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 15:15:03 UTC -1.0858 1.1658 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 14:45:03 UTC -1.0858 1.1658 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 14:15:03 UTC -1.0858 1.1658 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 13:45:03 UTC -1.0858 1.1658 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 13:15:04 UTC -1.0858 1.1658 200000
BOLT BIOTHERAPEUTICS INC BOLT 2021-08-02 12:45:03 UTC -1.0858 1.1658 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments